What is a peptide?
A peptide is a chain of amino acids, the same building blocks that make proteins. Many peptides in the body help carry signals between cells.
Get the basics A clearer starting point
Peptide science.
Made clear.
Curious about peptides? Start with the science. Understand the signals, explore the evidence, and learn what a study really tells us.
Plain-language explanationsPrimary sources linkedEvidence in context
THE SCIENCE OF SIGNALS01 / EXPLORE
01 Signal→02 Receptor→03 Response
One way to understand peptide signaling. Simplified illustration.
THE IMPORTANT DISTINCTION
A biological mechanism explains how something might work. A clinical trial asks what actually happens.
Read the evidence guide01 / YOUR STARTING POINT
A little context goes a long way.
Three ideas to keep with you as you explore.
What does a receptor do?
Think of a receptor as a cellular receiver. A matching signal can trigger a response. The response depends on the signal, the cell, and the context.
Follow the signalWhat counts as evidence?
A result in a cell, animal, or small human study answers different questions. None automatically tells us that a treatment helps everyone.
Learn to read a claimTHE BEGINNER GUIDE
Build your foundation.
No science background needed.
Peptides, proteins, and peptide medicines
Peptides and proteins are made from amino acids joined together. “Peptide” generally describes a shorter chain; the boundary is a naming convention, not a safety rule.
Some occur naturally in the body. Some medicines are designed to imitate or alter a biological signal. A familiar origin or a short chain does not make a substance automatically safe.
From a signal to a response
A receptor is a protein that can recognize a signal. When the signal interacts with it, a series of changes may follow inside or between cells. Different receptors and tissues can produce different responses.
Some peptides work in other ways. Elamipretide, for example, is studied for interactions with a fat in mitochondrial membranes. One simple “lock and key” picture cannot explain every peptide.
Natural, synthetic, and “research use”
“Natural” describes origin, not proven safety. “Synthetic” describes how something is made, not whether it works. “Research use only” is not an approval for human use.
Approval applies to a specific product and indication. It does not transfer automatically to a different preparation or a product sold under a similar name.
FDA: concerns about unapproved GLP-1 products ↗02 / THE EXPLAINER LIBRARY
Follow your curiosity.
Keep the evidence in view.
Four starting points. Each with the mechanism, the human context, and what we still don’t know.
No matching explainers yet.
Try “heart,” “sleep,” “cells,” or “hormones.”
A curated educational starting point, not a complete drug reference. Study results and approvals have specific limits.
THE RESEARCH LIBRARY
Browse the research Go beyond the headline.
Explore original papers across 25 compounds. See what was studied, what the researchers found, and where the evidence stops.
03 / THE EVIDENCE CHECK
Before you believe
the headline,
ask four questions.
A compelling mechanism is the beginning of a question. These checks help put a finding in context.
See our source approach01Who or what was studied?
Cells, animals, and people provide different kinds of evidence. In a human study, check the participants’ health conditions, age range, and other care. The result may not apply outside that group.
PRECLINICAL ≠ HUMAN OUTCOME02What was actually measured?
A change in a hormone, a lab marker, or an imaging result is not automatically a change in symptoms, fertility, lifespan, or quality of life. Name the endpoint before interpreting the claim.
MECHANISM ≠ PROVEN BENEFIT03Compared with what, and for how long?
Look for a comparison group, how participants were assigned, and the follow-up period. A short-term response cannot establish long-term safety or benefit.
Also compare absolute numbers. In SELECT, 6.5% versus 8.0% for the combined cardiovascular endpoint is a 1.5 percentage-point difference over about 40 months in the studied population.
04What are the limits and risks?
Check adverse effects, small sample sizes, uncertainty, and whether the work was exploratory or designed to test the outcome being claimed. Regulatory approval is specific to a product, use, and population.
Talk with a qualified clinician about treatment decisions. A science explainer cannot determine whether a medicine is appropriate for you.
04 / A CLOSER LOOK
Small lessons.
Worth a deeper look.
MORE FROM THE FEED
REEL · METABOLIC SIGNALINGMeet amylin.
Explore another piece of the signaling story.
CAROUSEL · GLP-1 SCIENCEGLP-1 & the brain.
A visual introduction to a complex connection.
Posts open on Instagram. Instagram may ask you to sign in.
COMING SOONMore room
More room
to go deeper.
This is the future home of Peptide Information ebooks: a place for longer, beginner-friendly explorations of the science.
No ebooks are available for purchase yet. Checkout and email sign-up are not active.
Find updates on InstagramA FEW COMMON QUESTIONS
Clarity starts
with good questions.
Is this medical advice?
No. This site offers general science education. It does not diagnose conditions, recommend treatments, or replace a conversation with a qualified healthcare professional. Do not start, stop, or change a prescribed treatment based on these pages.
Does “FDA-approved” mean every use is proven?
No. Approval applies to a specific product, indication, and population. It does not validate every claim about the underlying compound. Accelerated approval can rely on an endpoint that reasonably predicts benefit, with confirmatory evidence still required.
Do you provide dosing or places to buy peptides?
No. The focus here is understanding mechanisms, study findings, and their limitations. Individual treatment, dosing, and medicine access belong in a qualified clinical setting.
How are sources chosen?
We link to original peer-reviewed studies, official U.S. prescribing information, and FDA material. Each explainer separates the finding from its limits. The selected study is not an exhaustive review, and an older source may not capture later changes.
Browse source notes →TRACE THE CLAIM BACK
Good explanations
come with sources.
Sources reviewed October 10, 2026. Regulatory notes refer to the United States and may change. Open any explainer for its study details and specific limitations.
01
SELECT: semaglutide & cardiovascular outcomesLincoff et al. · New England Journal of Medicine · 2023
↗02SURMOUNT-OSA: tirzepatide & sleep apneaMalhotra et al. · New England Journal of Medicine · 2024
↗03Forzinity: approved use & accelerated approvalU.S. FDA · Prescribing information · PDF
↗04Kisspeptin-10: early human hormone responseGeorge et al. · Journal of Clinical Endocrinology & Metabolism · 2011
↗